Spinal Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Fusion Devices, Non-fusion Devices, Stimulation Devices), By Procedure Type (Discectomy, Laminotomy, Foraminotomy, Corpectomy, and Facetectomy), By Surgery Type (Open Surgery and Minimally Invasive Surgery), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics, and Others), and Region Forecast 2020-2031

Spinal Devices Market was valued at US$ 13,357.4 million in 2024 and is expected to reach US$ 17,109.6 million by 2031, growing at a significant CAGR of 3.6% from 2025-2031. Moreover, the U.S. Spinal Devices Market is projected to grow significantly, reaching an estimated value of US$ 5,338.2 Million by 2031.

The global market is defined as the segment of the healthcare industry dedicated to the development, production, and commercialization of medical devices used in the treatment, stabilization, and repair of spinal disorders and injuries. The global market is primarily driven by the rising prevalence of spinal disorders such as degenerative disc diseases and spinal stenosis, fueled by sedentary lifestyles and a rapidly aging global population. With over 600 million people suffering from lower back pain globally (WHO), the demand for spinal surgeries and implants is surging, particularly in regions with advanced healthcare infrastructure. The market is witnessing a strong trend toward robotic-assisted and AI-powered spinal procedures that enhance surgical accuracy and reduce intraoperative complications. Technologies like Medtronic’s Mazor X and Globus’s Excelsius GPS are at the forefront of this transformation, along with 3D-printed implants and a shift to outpatient spine surgeries.

A major opportunity lies in the expansion of minimally invasive spinal (MIS) procedures, supported by the growing need for reduced recovery time and cost-effective care, especially in aging populations. Furthermore, emerging markets are showing significant potential with increased investments in ambulatory surgical centers and biologic solutions for spinal fusion. However, the market faces restraints due to the high cost of implants and surgeries, inconsistent reimbursement policies, and regulatory complexities, especially in developing regions. Addressing these financial and policy-related barriers is crucial to enabling broader adoption and sustained innovation in the spinal devices landscape.

Facts & Figures 

• Aging Population & Rise in Spinal Disorders: As life expectancy increases, the prevalence of age-related spinal conditions like degenerative disc disease and spinal stenosis also rises. For instance, according to the WHO 2023 report, over 600 million people globally suffer from lower back pain, which is the leading cause of disability. Countries like Japan, Germany, and Italy, where over 20% of the population is aged 65+, are major contributors to market demand.
• Surge in Spinal Trauma and Sports Injuries: An increase in road accidents and athletic injuries is directly contributing to surgical interventions using spinal implants. For instance, the WHO 2023 Global Status Report on Road Safety indicates over 50 million non-fatal injuries globally every year, a portion of which are spinal trauma cases.
• Expansion of Outpatient Surgical Centers (ASCs): ASCs (Outpatient Surgical Centers) are becoming popular for cost-effective spinal surgeries, especially in developed markets like the USA. For instance, according to the Ambulatory Surgery Center Association (ASCA), over 60% of spinal procedures in the U.S. were performed in ASCs by late 2023 due to reduced costs and faster recovery pathways.
• Technological Advancements in Robotics and Navigation Systems: Precision-driven robotic platforms are improving surgical outcomes, reducing error, and driving adoption in developed healthcare markets. For instance, Medtronic’s Mazor X technique is widely adopted in U.S. surgical centers.

Recent Developments

• In April 2025, Globus Medical completed a $250?million acquisition of Nevro to enter the high-growth spinal cord stimulation (SCS) segment, positioning the company to address the chronic pain market ($2.5?billion) and leverage cross-platform innovation.
• In February 2025, Medtronic acquired Osteo-Sync titanium surface tech from Nanovis to enhance fusion implant integration and osteointegration performance.
• In October 2024, Stryker expanded its interventional pain portfolio by acquiring Vertos Medical, specializing in minimally invasive lumbar decompression, enhancing its non-fusion surgical offerings.
• In September 2024, Medtronic announced a global collaboration with Siemens Healthineers to integrate Multitom Rax imaging into its AiBLE™ surgical ecosystem, enhancing pre? and post-operative spine imaging.

Spinal Devices Market Segmentation

Based on the product type

• Fusion Devices
  • Cervical Devices
  • Thoracolumbar Devices
  • Interbody Devices
  • Biologics
• Non-fusion Devices
  • Vertebral Compression Fracture Devices
  • Artificial Discs
  • Dynamic Stabilization Devices
  • Others
• Stimulation Devices

Fusion devices hold the largest market share in the global market due to their long-established clinical efficacy in treating spinal deformities, degenerative disc disease, and trauma-related conditions. These devices provide long-term spinal stability and pain relief, making them the standard of care in spinal fusion surgeries. High prevalence of conditions like spinal stenosis and spondylolisthesis, especially among aging populations in North America and Europe, has driven their widespread adoption. Moreover, advancements in minimally invasive fusion techniques and biologics have further strengthened their demand. In contrast, stimulation devices currently hold the smallest market share, as their adoption is still emerging and often limited to complex or chronic pain cases.

Based on the procedure type 

• Discectomy
• Laminotomy
• Foraminotomy
• Corpectomy
• Facetectomy

The discectomy holds the largest market share in the market. This is primarily because it is one of the most common and effective surgical treatments for herniated discs, which are highly prevalent in patients with lower back and leg pain. Discectomy is a minimally invasive procedure, often performed using advanced tools and navigation systems, and offers rapid recovery, reduced hospital stays, and significant pain relief, factors that make it highly preferred by both patients and surgeons. Moreover, the rising aging population and sedentary lifestyles continue to fuel demand for this procedure. On the other hand, facetectomy holds a smaller share, as it is typically reserved for more complex spinal decompression cases involving facet joint disorders.

Based on the surgery type 

• Open Surgery
• Minimally Invasive Surgery

Minimally Invasive Surgery (MIS) holds the largest and fastest-growing share in the market due to its advantages in precision, recovery, and reduced complications. With advancements in navigation, minimally invasive surgery (MIS) systems, robotic-assisted tools, and tubular retractors, MIS allows surgeons to perform complex spinal procedures with minimal tissue disruption. Patients benefit from shorter hospital stays, faster rehabilitation, less blood loss, and lower postoperative infection risks, driving higher adoption rates, particularly among the elderly and active working populations. Hospitals also prefer MIS due to its cost-efficiency and faster turnover. In contrast, open surgery is seeing a gradual decline in share, as it involves larger incisions, longer recovery periods, and higher postoperative risks, making it less favored in modern clinical practice.

Based on the end user 

• Hospitals & Ambulatory Surgery Centers (ASCs)
• Specialty Clinics
• Others

Hospitals & Ambulatory Surgery Centers (ASCs) dominate the global market due to their advanced infrastructure, availability of skilled surgeons, and capacity to perform complex spinal procedures, including minimally invasive and robotic-assisted surgeries. These settings are preferred for both elective and emergency spinal operations as they provide integrated care, imaging, and post-surgical rehabilitation. ASCs, in particular, are gaining popularity for cost-effective outpatient spine surgeries with quicker turnaround times. On the other hand, specialty clinics, while growing, hold a smaller market share due to limited surgical facilities and fewer high-tech devices, mainly offering conservative treatments and follow-up care rather than major interventions.